Discovery of Hyperpolarized Molecular Imaging Biomarkers in a Novel Prostate Tissue Slice Culture Model

Abstract

Our goal in year 2 was to use the tissue slice (TSC) NMR compatible bioreactor optimized in year 1 to identify hyperpolarized metabolic biomarkers of prostate cancer presence and aggressiveness. To accomplish this goal my group finished the engineering of a 5 mm bioreactor and acquired hyperpolarized [1-13C]pyruvate data indicating that similar signal to noise and quality data can be achieved with 4 to 5 prostate tissue slices in the 5 mm bioreactor as was acquired from 30-40 tissue slices in the prior 10 mm bioreactor. The time course of viability of the tissue slices prior to and after the bioreactor 5 mm bioreactor study was also established using a live-dead tissue assays performed by the co-PI s Peehl and Ronen on this proposal. We subsequently utilized this optimized 5 mm bioreactor in hyperpolarized [1-13C] MR studies to begin correlating hyperpolarized [1-13C] pyruvate metabolism with pathologic grade (aim 2) and observed a grade dependent increase in the flux of hyperpolarized [1-13C]pyruvate to [1-13C]lactate, with higher levels of lactate in higher pathologic grade cancers. More cancer TSCs need to be studied to demonstrate biologic significance.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2013
Accession Number
ADA584506

Entities

People

  • John Kurhanewicz

Organizations

  • University of California, San Francisco

Tags

DTIC Thesaurus Topics

  • Androgens
  • Biological Markers
  • Biomedical Research
  • Bioreactors
  • Data Acquisition
  • Engineering
  • Magnetic Resonance
  • Metabolism
  • Neoplasms
  • Prostate
  • Prostate Cancer
  • Pyruvates
  • Spectra
  • Steady State
  • Three Dimensional
  • Tissue Culture
  • Viability

Fields of Study

  • Biology
  • Medicine

Readers

  • Cardiovascular Physiology
  • Groundwater Contamination Remediation.
  • Oncology and Biomarker-Based Cancer Detection.

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech